New study tracks Acalabrutinib's Real-World success in CLL patients
NCT ID NCT05999877
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 192 people with chronic lymphocytic leukemia (CLL) in Spain who started taking acalabrutinib for the first time. Researchers want to see how many patients stay on the drug for at least 24 months and how it works in different groups, like those new to treatment or switching due to side effects from an older drug. The goal is to understand real-world outcomes, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
acalabrutinib
What this could lead to
If successful, this could show that acalabrutinib is a well-tolerated and effective first-line treatment for chronic lymphocytic leukemia, helping patients stay on therapy longer.
What could go wrong
This is an observational study, not a controlled trial, so results may not prove cause and effect. It only includes patients in Spain, so findings may not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Almería, Andalusia, 4009, Spain
-
Research Site
Córdoba, Andalusia, 14004, Spain
-
Research Site
Granada, Andalusia, 18014, Spain
-
Research Site
Jaén, Andalusia, 23007, Spain
-
Research Site
Marbella, Andalusia, 29603, Spain
-
Research Site
Málaga, Andalusia, 29010, Spain
-
Research Site
Seville, Andalusia, 41013, Spain
-
Research Site
Zaragoza, Aragon, 50009, Spain
-
Research Site
Palma de Mallorca, Balearic Islands, 7010, Spain
-
Research Site
Palma de Mallorca, Balearic Islands, 7198, Spain
-
Research Site
Las Palmas de Gran Canaria, Canary Islands, 35016, Spain
-
Research Site
Las Palmas de Gran Canaria, Canary Islands, 35019, Spain
-
Research Site
San Cristóbal de La Laguna, Canary Islands, 38320, Spain
-
Research Site
Santander, Cantabria, 39008, Spain
-
Research Site
Salamanca, Castille and León, 37007, Spain
-
Research Site
Segovia, Castille and León, 40002, Spain
-
Research Site
Valladolid, Castille and León, 47003, Spain
-
Research Site
Valladolid, Castille and León, 47012, Spain
-
Research Site
Guadalajara, Castille-La Mancha, 19002, Spain
-
Research Site
Toledo, Castille-La Mancha, 45004, Spain
-
Research Site
Barcelona, Catalonia, 8003, Spain
-
Research Site
Barcelona, Catalonia, 8025, Spain
-
Research Site
Barcelona, Catalonia, 8035, Spain
-
Research Site
Barcelona, Catalonia, 8036, Spain
-
Research Site
Granollers, Catalonia, 8402, Spain
-
Research Site
L'Hospitalet de Llobregat, Catalonia, 8908, Spain
-
Research Site
Lleida, Catalonia, 25198, Spain
-
Research Site
Terrassa, Catalonia, 8221, Spain
-
Research Site
Ourense, Galicia, 32005, Spain
-
Research Site
Santiago de Compostela, Galicia, 15706, Spain
-
Research Site
Vigo, Galicia, 36312, Spain
-
Research Site
Madrid, Madrid, 28006, Spain
-
Research Site
Madrid, Madrid, 28031, Spain
-
Research Site
Madrid, Madrid, 28034, Spain
-
Research Site
Madrid, Madrid, 28040, Spain
-
Research Site
Madrid, Madrid, 28041, Spain
-
Research Site
Madrid, Madrid, 28046, Spain
-
Research Site
Madrid, Madrid, 28905, Spain
-
Research Site
Madrid, Madrid, 28911, Spain
-
Research Site
Majadahonda, Madrid, 28222, Spain
-
Research Site
El Palmar, Murcia, 30120, Spain
-
Research Site
Murcia, Murcia, 30008, Spain
-
Research Site
Oviedo, Principality of Asturias, 33011, Spain
-
Research Site
Alicante, Valencia, 3010, Spain
-
Research Site
Valencia, Valencia, 46010, Spain
-
Research Site
Valencia, Valencia, 46014, Spain
-
Research Site
Valencia, Valencia, 46026, Spain